We are live on ! Find out more
NI

Nepsis Inc Portfolio holdings

AUM $295M
1-Year Est. Return 35.44%
This Fund
S&P 500
This Quarter Est. Return
+1.81%
1 Year Est. Return
+35.44%
3 Year Est. Return
+115.51%
5 Year Est. Return
+196.69%
10 Year Est. Return
+848.99%
AUM
$371M
AUM Growth
+$1.29M
Cap. Flow
+$2.52M
Cap. Flow %
0.68%
Top 10 Hldgs %
56.09%
Holding
29
New
1
Increased
17
Reduced
9
Closed
1

Top Buys

Rank Stock Value
1
CAVA icon
CAVA Group
CAVA
+$10.9M
2
AMAT icon
Applied Materials
AMAT
+$4.35M
3
AMD icon
Advanced Micro Devices
AMD
+$2.93M
4
WBD icon
Warner Bros
WBD
+$1.89M
5
RLI icon
RLI Corp
RLI
+$1.83M

Top Sells

Rank Stock Value
1
FFIV icon
F5
FFIV
+$11.8M
2
BMY icon
Bristol-Myers Squibb
BMY
+$10.3M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.23M
4
QCOM icon
Qualcomm
QCOM
+$420K
5
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$69K

Sector Composition

Rank Sector Weight
1 Financials 28.18%
2 Technology 27.22%
3 Healthcare 16.4%
4 Energy 10.11%
5 Communication Services 8.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DUK icon
26
Duke Energy
DUK
$97.8B
$1.63M 0.44%
16,298
-341
-2% -$34.1K
ORCL icon
27
Oracle
ORCL
$374B
$343K 0.09%
2,428
– –
BMY icon
28
Bristol-Myers Squibb
BMY
$133B
$236K 0.06%
5,690
-230,591
-98% -$10.3M
FFIV icon
29
F5
FFIV
$22.9B
– –
-62,198
Closed -$11.8M
1
2

Similar funds

CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
PC
Permit Capital West Conshohocken, Pennsylvania $294M AUM 27.9% 1-Year Est. Return
SM
Selkirk Management Chatham, New Jersey $294M AUM 26.84% 1-Year Est. Return
BIC
B&I Capital Zurich, Switzerland $294M AUM 3.09% 1-Year Est. Return
TJHA
Thomas J. Herzfeld Advisors Miami Beach, Florida $294M AUM 2.62% 1-Year Est. Return
FRA
Front Row Advisors Tiburon, California $296M AUM 34.73% 1-Year Est. Return
SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return

Nepsis Inc's Q2 2024 Portfolio in Review

As of Q2 2024, Nepsis Inc held 29 positions worth $371M, up 0.35% from $370M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Nepsis Inc's Q2 2024 filing shows 1 new, 17 increased, 9 reduced and 1 closed positions. Its largest new stake was CAVA Group: 141,127 shares worth $13.1M. The largest sale was F5, an estimated $11.8M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

  • Nepsis Inc's largest Q2 2024 buy was CAVA Group: 141,127 shares worth $13.1M.
  • Nepsis Inc added most to Applied Materials in Q2 2024, an estimated $4.35M increase.
  • Nepsis Inc's biggest Q2 2024 reduction was Bristol-Myers Squibb, cutting an estimated $10.3M.
  • Nepsis Inc fully exited F5 in Q2 2024, selling an estimated $11.8M.
  • Nepsis Inc's ten largest holdings make up 56% of its $371M portfolio in Q2 2024.
  • Nepsis Inc opened 1 new position and closed 1 in Q2 2024.
  • Nepsis Inc's portfolio value rose 0.35% quarter-over-quarter to $371M.

Based on Nepsis Inc's 13F filing for Q2 2024, filed 15 Jul 2024.